Efficacy of inhaled rhDNase for acute asthma in childhood.

Trial Profile

Efficacy of inhaled rhDNase for acute asthma in childhood.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Nov 2011

At a glance

  • Drugs Dornase alfa (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 May 2009 Trial sponsor (Roche), lead trial centre (Roche Nederland), investigator (Boogaard R) added as reported by ISRCTN: Current Controlled Trials.
    • 27 Dec 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top